Here, we derive an anti-mouse GARP:TGF-β1 mAb that blocks release of active TGF-β1 by mouse Tregs, allowing to examine the therapeutic benefit of blocking Treg function in tumor-bearing individuals. The gene discussed is TGFB1; the disease is neoplasm.